AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

CTNM · NASDAQ · Biotechnology

Contineum Therapeutics (CTNM)

Discovers and develops oral small-molecule therapies for neuroscience, inflammation and immunology.

$17.24

At close+0.69 (+4.14%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions91 holders · as of Mar 31, 2026	81.22%	30.56M shares
Insiders3 holders · as of Aug 3, 2026	0.44%	166.0K shares
Otherremainder	18.34%	6.90M shares

37.62M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Suvretta Capital Management, LLCInstitution	7.55%	2.84M A	13Fas of Mar 31, 2026
Janus Henderson Group PLCInstitution	7.27%	2.73M A	13Fas of Mar 31, 2026
Johnson & JohnsonInstitution	5.26%	1.98M A	13Fas of Mar 31, 2026
Franklin Resources IncInstitution	4.89%	1.84M A	13Fas of Mar 31, 2026
Balyasny Asset Management L.P.Institution	4.48%	1.69M A	13Fas of Mar 31, 2026
Millennium Management LLCInstitution	4.08%	1.54M A	13Fas of Mar 31, 2026
Baker Bros. Advisors LPInstitution	3.78%	1.42M A	13Fas of Mar 31, 2026
Ra Capital Management, L.P.Institution	3.44%	1.30M A	13Fas of Mar 31, 2026
Perceptive Advisors LLCInstitution	3.34%	1.26M A	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	3.23%	1.21M A	13Fas of Mar 31, 2026
FMR LLCInstitution	2.17%	814,871 A	13Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution	2.15%	807,874 A	13Fas of Mar 31, 2026
Great Point Partners LLCInstitution	2.13%	800,198 A	13Fas of Mar 31, 2026
Longaeva Partners L.P.Institution	1.95%	732,088 A	13Fas of Mar 31, 2026
Sectoral Asset Management IncInstitution	1.93%	727,587 A	13Fas of Mar 31, 2026
HHLR Advisors, Ltd.Institution	1.78%	669,337 A	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	1.78%	669,123 A	13Fas of Mar 31, 2026
Red Tree Management, LLCInstitution	1.70%	638,158 A	13Fas of Mar 31, 2026
Versant Venture Management, LLCInstitution	1.44%	542,628 A	13Fas of Mar 31, 2026
Jones Hill Capital LPInstitution	1.36%	513,053 A	13Fas of Mar 31, 2026
Boxer Capital Management, LLCInstitution	1.31%	494,000 A	13Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution	0.99%	371,636 A	13Fas of Mar 31, 2026
Citadel Advisors LLCInstitution	0.93%	350,200 A	13Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution	0.82%	307,108 A	13Fas of Mar 31, 2026
Silverarc Capital Management, LLCInstitution	0.80%	301,729 A	13Fas of Mar 31, 2026

13F — a manager's quarterly holdings

Institutions13F, as of Mar 31, 2026

91 holders · 30.56M shares · 22 new positions · 51 increased · 21 reduced · 12 closed

Holder	Shares	% of company	Chg q/q	Filed
Suvretta Capital Management, LLC	2.84M	7.55%	0	May 15, 2026
Janus Henderson Group PLC	2.73M	7.27%	+285.9K	May 18, 2026
Johnson & Johnson	1.98M	5.26%	0	May 13, 2026
Franklin Resources Inc	1.84M	4.89%	−40.1K	May 13, 2026
Balyasny Asset Management L.P.	1.69M	4.48%	−157.2K	May 15, 2026
Millennium Management LLC	1.54M	4.08%	+704.8K	May 15, 2026
Baker Bros. Advisors LP	1.42M	3.78%	0	May 15, 2026
Ra Capital Management, L.P.	1.30M	3.44%	−883.7K	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Janus Henderson Group PLC	7.90%	2.45M	13G	Feb 17, 2026 ↗
Balyasny Asset Management L.P.	7.40%	2.42M	13G	May 15, 2026 ↗
BlackRock, Inc.	6.30%	2.05M	13G	Jul 27, 2026 ↗
Franklin Resources, Inc.	6.20%	1.88M	13G	Jan 29, 2026 ↗
Millennium Management LLC	5.10%	1.66M	13G	Apr 17, 2026 ↗
Jérôme G. Pfundincl. Sectoral Asset Management Inc.	5.00%	950.9K	13G	Nov 14, 2024 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Aug 3, 2026	Carmine N. Stengonedirector, officer: CEO and President	Sale	2,500	$16.01	17,217
Jul 9, 2026	Daniel S. Lorrainofficer: Chief Scientific Officer	Sale	25	$16.00	135,202
Jul 8, 2026	Carmine N. Stengonedirector, officer: CEO and President	Sale	2,500	$16.00	17,217
Jul 1, 2026	Daniel S. Lorrainofficer: Chief Scientific Officer	Sale · 2 lots	8,353	$15.84	135,202
Jun 30, 2026	Daniel S. Lorrainofficer: Chief Scientific Officer	Sale	28,826	$16.04	139,372
Jun 30, 2026	Carmine N. Stengonedirector, officer: CEO and President	Sale	10,000	$16.01	17,217
Jun 30, 2026	Tim Watkinsofficer: CMO & Head of Development	Sale	10,833	$16.02	8,961
Jun 1, 2026	Daniel S. Lorrainofficer: Chief Scientific Officer	Sale	4,170	$13.16	139,372
May 1, 2026	Daniel S. Lorrainofficer: Chief Scientific Officer	Sale · 2 lots	4,170	$13.12	143,542
Apr 6, 2026	Daniel S. Lorrainofficer: Chief Scientific Officer	Sale	4,170	$13.43	147,712

CongressHouse and Senate disclosures

Not reported.